BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 33112908)

  • 21. Teaching Conflicts of Interest and Shared Decision-Making to Improve Risk Communication: a Randomized Controlled Trial.
    Koch C; Dreimüller N; Weißkircher J; Deis N; Gaitzsch E; Wagner S; Stoll M; Bäßler F; Lieb K; Jünger J
    J Gen Intern Med; 2020 Feb; 35(2):473-480. PubMed ID: 31823309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physicians' Understanding of Clinical Trial Data in Professional Prescription Drug Promotion.
    Moynihan CK; Burke PA; Evans SA; O'Donoghue AC; Sullivan HW
    J Am Board Fam Med; 2018; 31(4):645-649. PubMed ID: 29986991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Medicines Information and the Regulation of the Promotion of Pharmaceuticals.
    Leonardo Alves T; Lexchin J; Mintzes B
    Sci Eng Ethics; 2019 Aug; 25(4):1167-1192. PubMed ID: 29721844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addressing the hidden curriculum in the clinical workplace: A practical tool for trainees and faculty.
    Mulder H; Ter Braak E; Chen HC; Ten Cate O
    Med Teach; 2019 Jan; 41(1):36-43. PubMed ID: 29490529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conflicts of Interest in Medicine. A Systematic Review of Published and Scientifically evaluated Curricula.
    Weißkircher J; Koch C; Dreimüller N; Lieb K
    GMS J Med Educ; 2017; 34(3):Doc37. PubMed ID: 28890928
    [No Abstract]   [Full Text] [Related]  

  • 27. Prescribers' Knowledge and Skills for Interpreting Research Results: A Systematic Review.
    Kahwati L; Carmody D; Berkman N; Sullivan HW; Aikin KJ; DeFrank J
    J Contin Educ Health Prof; 2017; 37(2):129-136. PubMed ID: 28562502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Medical Students' Opinions About the Commercialization of Healthcare: A Cross-Sectional Survey.
    Civaner MM; Balcioglu H; Vatansever K
    J Bioeth Inq; 2016 Jun; 13(2):261-70. PubMed ID: 26781432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Awareness of the Food and Drug Administration's Bad Ad Program and Education Regarding Pharmaceutical Advertising: A National Survey of Prescribers in Ambulatory Care Settings.
    O'Donoghue AC; Boudewyns V; Aikin KJ; Geisen E; Betts KR; Southwell BG
    J Health Commun; 2015; 20(11):1330-6. PubMed ID: 26176326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medical school gift restriction policies and physician prescribing of newly marketed psychotropic medications: difference-in-differences analysis.
    King M; Essick C; Bearman P; Ross JS
    BMJ; 2013 Jan; 346():f264. PubMed ID: 23372175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does exposure to conflict of interest policies in psychiatry residency affect antidepressant prescribing?
    Epstein AJ; Busch SH; Busch AB; Asch DA; Barry CL
    Med Care; 2013 Feb; 51(2):199-203. PubMed ID: 23142772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sale strategies of pharmaceutical companies in a "pharmerging" country: the problems will not improve if the gaps remain.
    Civaner M
    Health Policy; 2012 Aug; 106(3):225-32. PubMed ID: 22682762
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knowledge, attitude and skills before and after a module on pharmaceutical promotion in a Nepalese medical school.
    Shankar PR; Singh KK; Piryani RM
    BMC Res Notes; 2012 Jan; 5():8. PubMed ID: 22221485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of educational interventions and medical school policies on medical students' attitudes toward pharmaceutical marketing practices: a multi-institutional study.
    Kao AC; Braddock C; Clay M; Elliott D; Epstein SK; Filstead W; Hotze T; May W; Reenan J
    Acad Med; 2011 Nov; 86(11):1454-62. PubMed ID: 21952057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Medical students' exposure to and attitudes about the pharmaceutical industry: a systematic review.
    Austad KE; Avorn J; Kesselheim AS
    PLoS Med; 2011 May; 8(5):e1001037. PubMed ID: 21629685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Do medical students copy the drug treatment choices of their teachers or do they think for themselves?
    Tichelaar J; Richir MC; Avis HJ; Scholten HJ; Antonini NF; De Vries TP
    Eur J Clin Pharmacol; 2010 Apr; 66(4):407-12. PubMed ID: 19937005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exposure of medical students to pharmaceutical marketing in primary care settings: frequent and influential.
    Sarikaya O; Civaner M; Vatansever K
    Adv Health Sci Educ Theory Pract; 2009 Dec; 14(5):713-24. PubMed ID: 19184498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating professionalism teaching into undergraduate medical education in the UK setting.
    Goldie J
    Med Teach; 2008 Jun; 30(5):513-27. PubMed ID: 18576191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exposing nursing students to the marketing methods of pharmaceutical companies.
    Civaner M; Sarikaya O; Alici SU; Bozkurt G
    Nurs Ethics; 2008 May; 15(3):396-410. PubMed ID: 18388173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?
    Carroll AE; Vreeman RC; Buddenbaum J; Inui TS
    Pediatrics; 2007 Dec; 120(6):e1528-35. PubMed ID: 18055668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.